General Western Blot Reagents
Abcam D-Fructose 6-phosphate disodium salt hydrate, Glycolytic intermediate, 500MG
MW 304.1 g/mol, Purity >98%. Sugar intermediate of the glycolytic pathway produced by the isomerization of glucose-6-phosphate by phosphoglucoisomerase.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ca2+/Calmodulin Solution 10 x , 500UL
10x stock solution used for assaying protein kinase activity of CAMK family members.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Olanzapine, 5-HT, dopamine, histamine and muscarinic antagonist, 10MG
MW 312.43 g/mol, Purity >99%. 5-HT and D₂ antagonist (Ki values are 4 (5-HT₂A), 11 (5-HT₂C) and 57 (5-HT₃), 31 (D₁), 11 (D₂) and 27 nM (D₄)). Additionally, displays activity at: M₁, M₂, M₃, M₄, H₁, α₁ and α₂ receptors (Ki are 1.9 at (M₁), 18 (M₂), 25 (M₃), 13 (M₄), 19 (α₁) and 7 nM (α₂)). Atypical antipsychotic. Displays anxiolytic activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bisindolylmaleimide x I hydrochloride, PKC inhibitor, 5MG
MW 489 Da, Purity >98%. Selective, cell-permeable protein kinase C (PKC) inhibitor that displays 10-fold greater selectivity for PKCα (IC₅₀ = 9 nM) and 4-fold greater selectivity for PKCβI (IC₅₀ = 28 nM) over Ca²+-independent PKCε (IC₅₀ = 108 nM). Enhances cardiac contractility and protection from heart failure. Prevents T-cell activation and proliferation (IC₅₀s ranging from 30-150 nM) associated with chronic inflammatory responses in vivo. Also inhibits GRK2, GRK5, and GRK6 (IC₅₀ values are 29, 3.6, and 16 μM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Antibiotic PF 1052, Neutrophil migration inhibitor, 1MG
MW 429.59 g/mol, Purity >98%. Neutrophil migration inhibitor. Antibacterial and potentially antifungal and phytotoxic properties. Active in vivo and in vitro. See similar compound
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Bisoprolol hemifumarate, beta1 antagonist, 50MG
MW 383.48 g/mol, Purity >99%. Selective β₁ antagonist (Ki = 22.4 nM). Antihypertensive agent.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Marimastat, Matri x metalloprotease (MMP) inhibitor, 10MG
MW 331.41 Da, Purity >98%. Potent matrix metalloproteinase inhibitor. Broad-spectrum inhibitor of all major MMPs. Prevents or reduces spread and growth of tumors.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ICI 182,780, Estrogen receptor antagonist, 5MG
MW 606.8 Da, Purity >99%. Estrogen receptor antagonist with no partial agonist activity. Anticancer agent (IC₅₀ = 0.29 nM for inhibition of breast cancer cell growth). Causes downregulation and loss of estrogen receptors.
The product is subject to the following: Abcam Restricted Use Statement
Abcam alpha-Calcitonin Gene Related Peptide (human), CGRP agonist, 500UG
MW 3789.3 Da, Purity >95%. alpha-Calcitonin Gene Related Peptide (human), CGRP agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Venlafa x ine hydrochloride, Serotonin-norepinephrine reuptake inhibitor, 50MG
MW 313.87 g/mol, Purity >99%. Serotonin-norepinephrine reuptake inhibitor. Ki values are 82 and 2480 nM for SERT and NET, respectively. Displays 30-fold higher affinity for SERT than NET in vitro. Antidepressant.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Deltamethrin, protein phosphatase 2B inhibitor, 50MG
MW 505.2 Da, Purity >98%. Potent protein phosphatase 2B inhibitor (IC₅₀ = 0.03 nM). Induces neurotoxicity by slowing the opening and closing of Na+ channels. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Jagged1 peptide, 1MG
Human Jagged1 peptide is a Synthetic blocking peptide. >70% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: CD339, JAGL1, JAG1, Protein jagged-1, Jagged1, hJ1
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fluconazole, Cytochrome P450 inhibitor, 50MG
MW 306.27 Da, Purity >99%. Triazole antifungal agent. Cytochrome P450 inhibitor (IC₅₀ values are 30.3, 12.3, 13.1 μM for CYP2C9, CYP2C19 and CYP3A4, respectively). Penetrates the blood-brain barrier.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Collagen III peptide, 1MG
Human Collagen III peptide is a Synthetic blocking peptide. >70% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: Collagen alpha-1(III) chain, COL3A1
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Histone H3 (unmodified) peptide, 500UG
Human Histone H3 (unmodified) peptide is a Synthetic blocking peptide. >90% purity and suitable for Dot, BL.
Protein/ Peptide/ Enzyme Synonyms: H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3C1, H3FC, HIST1H3C, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement